Association Between BMI and COVID-19 (BMI-SARS-CoV-2)

March 25, 2021 updated by: University Hospital, Lille

Relationship Between Obesity and Severe Acute Respiratory Syndrome Coronavirus-2 in Patient With SARS-CoV-2 Admitted in Intensive Care : A Multicenter Retrospective Cohort Study

This study will involve collection of pseudonymized data from hospital-based data reporting at multiple international sites. Collating data from a large volume of patients with COVID-19 admitted in ICU across multiple international sites will enable investigation of whether obesity is a risk factor for complicated from of SARS-CoV-2 in adult patients and whether this association is independent of other cardiometabolic risk factors.

Study Overview

Status

Completed

Conditions

Detailed Description

The COVID-19 pandemic is characterized by a high frequency of patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), who often require invasive mechanical ventilation (IMV). Body mass index (BMI) was however rarely mentioned in early clinical reports.

Disease severity gradually increased with body mass index (BMI) categories among patients admitted in intensive care unit (ICU) for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the need for invasive mechanical ventilation (IMV), reaching 85% in patients with class II or III obesity ( BMI > 35 kg/m2).

In summary, there is an urgent need for more evidence on the specific role played by obesity in the development of COVID-19 complications, and more particularly of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Study Type

Observational

Enrollment (Actual)

1200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lille, France, 59100
        • Centre Hospitalier Régional & Universitaire de Lille (CHRU)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients admitted to Intensive Care Unit for SARS-CoV-2

Description

Inclusion Criteria:

  • Participant is aged 18 years or over
  • Has been admitted to ICU with COVID-19 disease.
  • COVID-19 disease has been confirmed by PCR for SARS-CoV-2
  • Height and weight or BMI on admission has been recorded
  • Data has been collected in an ethical manner as part of a national database or clinical auditing process approved by the local institution or collaboration

Exclusion Criteria:

-There are no exclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
BMI SARS-CoV-2
Patients admitted to Intensive Care Unit with SARS-CoV-2
Patients admitted to Intensive Care Unit with SARS-CoV2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relationship between body mass index (BMI) and SARS-CoV-2
Time Frame: 3 months
The primary objective of this study is to investigate the relationship between obesity, as determined by body mass index (BMI), and severe pneumonia, as defined by the need of invasive mechanical ventilation ( IMV), among patient admitted in ICU for SARS-CoV-2, across multiple centers, in multiple countries.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Associations between BMI and outcomes is independent of the known cardiometabolic risk factors
Time Frame: 3 months
Investigate whether the associations between BMI and outcomes is independent of the known cardiometabolic risk factors, hypertension, diabetes, dyslipidemia, and current smoking.
3 months
Investigate the modifying effects of age and sex on the associations between BMI and outcome: Invasive mechanical ventilation
Time Frame: 3 months
Investigate the modifying effects of age and sex on the associations between BMI and outcome: Invasive mechanical ventilation
3 months
Investigate the modifying effects of age and sex on the associations between BMI and outcome: mortality
Time Frame: 3 months
Investigate the modifying effects of age and sex on the associations between BMI and outcome: mortality
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Francois Pattou, MD, Centre Hospitalier Régional & Universitaire de Lille (CHRU)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

May 15, 2020

Study Completion (Actual)

September 1, 2020

Study Registration Dates

First Submitted

May 14, 2020

First Submitted That Met QC Criteria

May 14, 2020

First Posted (Actual)

May 18, 2020

Study Record Updates

Last Update Posted (Actual)

March 26, 2021

Last Update Submitted That Met QC Criteria

March 25, 2021

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • DEC20-095

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on SARS-CoV 2

Clinical Trials on Patients admitted to Intensive Care Unit with SARS-CoV2

Subscribe